Saudi Arabia and UK sign agreement to strengthen cooperation in veterinary medicines regulation
Saudi Arabia and the UK sign a Memorandum of Understanding (MOU) to strengthen bilateral cooperation on veterinary medicines regulation.
The Saudi Food and Drug Authority (SFDA) and the UK Veterinary Medicines Directorate (VMD) have signed a Memorandum of Understanding (MoU) to strengthen bilateral cooperation on the regulation of veterinary medicines to safeguard public and animal health.
The MoU was signed on the sidelines of the “DIA–MHRA Global Summit: Global Collaboration for Safer and Smarter Health Innovation”, held in London, by H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the SFDA, and Ms. Abigail Seager, Chief Executive Officer of the VMD.
H.E. Dr. Hisham S. Aljadhey, Chief Executive Officer of the SFDA, said:
We are delighted to establish this strategic partnership with the UK VMD, creating a comprehensive framework for regulatory collaboration, technical capacity building, and effective information exchange between Saudi Arabia and the UK. By uniting our efforts, we reinforce our commitment to advancing international regulatory cooperation, adopting the highest global standards, and strengthening our collective capabilities to protect animal health and ensure the safety, quality, and availability of veterinary products.
Abigail Seager, Chief Executive Officer of the VMD, said:
Protecting animal and public health depends on strong cooperation between regulators of veterinary medicines. This agreement with the SFDA provides an important opportunity for both countries to share scientific expertise and regulatory experience, and to learn from each other.
By working together, we can strengthen our approach to the regulation of veterinary medicines and support efforts to tackle shared challenges, including antimicrobial resistance.
Under the MoU, the SFDA and VMD will exchange information on the regulation and availability of veterinary medicines, as well as assessment reports and regulatory requirements for veterinary medicines. They will facilitate the exchange of experts and consultants and support training initiatives to share knowledge and experience.
The partnership will further facilitate discussions and the exchange of knowledge on regulatory policies and practices, laboratory testing standards, pre- and post-marketing controls and surveillance, market compliance assessments, manufacturer regulation, and efforts to address antimicrobial resistance (AMR).
Notes:
For press queries please contact the SFDA Intl.media@sfda.gov.sa or Defra Press Office newsdesk@defra.gov.uk